Yellox

Yellox contains bromfenac sodium sesquihydrate, a nonsteroidal anti-inflammatory drug (NSAID) used to reduce inflammation and pain in the eye following cataract surgery. After cataract removal, patients may experience inflammation and discomfort as part of the healing process. Bromfenac works by inhibiting cyclooxygenase (COX) enzymes that produce prostaglandins, chemicals responsible for causing pain and inflammation. By reducing these substances, bromfenac helps alleviate discomfort and speeds up recovery after surgery.
Yellox is administered as eye drops, typically once or twice a day, depending on the doctor’s recommendations. The treatment should be started shortly after surgery and used for a set period, usually up to two weeks, to manage inflammation effectively.
Bromfenac is well-tolerated, and most side effects are mild, such as eye irritation, stinging, or burning after the drops are applied. However, in rare cases, it may cause increased eye pressure or corneal damage. Patients should regularly follow up with their healthcare provider to monitor for potential adverse effects, especially if they have a history of eye conditions or glaucoma.
Yellox offers a convenient and effective solution to help patients recover from cataract surgery with minimal discomfort, ensuring a smoother recovery and improved vision outcomes. Regular use as directed supports better results and enhanced comfort during healing.